OSLO, Norway, Feb. 4, 2011 /PRNewswire/ -- Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, today announced positive results from its consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results